Creating a method to rejuvenate and expand human cells using synthetic RNA
Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules
This study is exploring a new way to help your own adult stem cells stay young and work better by using a special mix of synthetic RNA, which could make them more useful for treatments in regenerative medicine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11077770 on NIH RePORTER |
What this research studies
This research focuses on developing a new platform to rejuvenate and expand human somatic cells, particularly adult stem cells, using a synthetic RNA cocktail. The approach aims to counteract cellular aging by restoring telomere length and improving cell function without permanently altering the cells. Patients may benefit from this technology as it could enhance the availability and effectiveness of their own cells for therapeutic purposes, especially in regenerative medicine. The research involves innovative techniques that could lead to significant advancements in how we utilize human cells for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who may require regenerative therapies involving their own somatic cells.
Not a fit: Patients with conditions that do not involve somatic cell therapy or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with improved therapies that utilize their own rejuvenated cells for various medical treatments.
How similar studies have performed: Other research has shown promise in rejuvenating cells using similar RNA-based approaches, indicating potential for success in this novel application.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Kogut, Igor — University of Colorado Denver
- Study coordinator: Kogut, Igor
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.